Related Experiment Videos
Hybrids between human tumor cell strains differing in repair of MNNG-produced DNA damage
Abstract:
Human tumor cell strains with differing responses to MNNG damage in their DNA were treated with precipitates of the plasmids pSV2gpt or pSV2neo . Transfected clones were selected on the basis of the drug resistance which each plasmid confers. Cells with different drug resistances were fused and hybrids were selected in medium requiring the expression of both markers. Hybrids produced by fusion of two different strains hypersensitive to MNNG-produced cytotoxicity and which lack the DNA repair enzyme O6-methylguanine-DNA methyltransferase ( O6MT ) failed to show complementation, suggesting that these strains share a common genetic defect. Hybrids from fusions of each of three strains containing O6MT activity with the same strain lacking O6MT activity were of surprising character. In one case the hybrid had resistance to MNNG-produced cell killing and O6MT activity similar to the parent strain possessing O6MT activity. In a second case, the hybrid had greater resistance to MNNG produced cytotoxicity than either parent strain although the level of O6MT activity was not higher. In a third case, the hybrid had little or no O6MT and as great hypersensitivity to MNNG-produced cytotoxicity as the parent strain lacking O6MT activity. We conclude that the survival of human tumor cell strains after MNNG-produced DNA damage is controlled by several genes. Even individual repair enzymes, like O6MT , are likely to be regulated by the interaction of these genes.
Insights
Human tumor cells
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- DNA repair mechanisms are crucial for cellular survival.
- N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) is a DNA-damaging agent.
- O6-methylguanine-DNA methyltransferase (O6MT) is a key DNA repair enzyme.
Purpose of the Study:
- To investigate the genetic control of human tumor cell survival after MNNG-induced DNA damage.
- To explore the role of O6MT in DNA repair and cellular resistance to MNNG.
- To identify potential genetic defects in MNNG-hypersensitive cell strains.
Main Methods:
- Transfection of human tumor cell strains with plasmids pSV2gpt or pSV2neo.
- Selection of drug-resistant clones.
- Cell fusion experiments to create hybrid cells.
- Assay of MNNG cytotoxicity and O6MT activity in parent and hybrid cells.
Main Results:
- MNNG-hypersensitive cell strains lacking O6MT showed no complementation, indicating a shared genetic defect.
- Hybrid cells exhibited varied responses to MNNG, with some showing enhanced resistance independent of O6MT levels.
- Some hybrids displayed hypersensitivity to MNNG, similar to the O6MT-deficient parent.
Conclusions:
- Multiple genes regulate human tumor cell survival following MNNG-induced DNA damage.
- The DNA repair enzyme O6MT is likely subject to complex genetic regulation through gene interactions.
- Understanding these genetic interactions is vital for cancer therapy development.